Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC007066 | Panoply™ Human HIST2H2BE Knockdown Stable Cell Line | Inquiry |
| CSC-SC007066 | Panoply™ Human HIST2H2BE Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD07553Z | Human HIST2H2BE adenoviral particles | Inquiry |
| LV14694L | human HIST2H2BE (NM_003528) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH123635 | shRNA set against Human HIST2H2BE(NM_003528.2) | Inquiry |
| SHH309886 | shRNA set against Human H2B (NM_001024599.3) | Inquiry |
| SHH309890 | shRNA set against Mouse H2B (NM_001110555.1) | Inquiry |
| SHH309894 | shRNA set against Rat H2B (NM_001106114.1) | Inquiry |
| SHH312917 | shRNA set against Mouse HIST2H2BE (NM_178214.3) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFH008544 | Human HIST2H2BE cDNA Clone(NM_003528.2) | Inquiry |
| MiUTR1H-04567 | HIST2H2BE miRNA 3'UTR clone | Inquiry |
| MiUTR1M-05679 | HIST2H2BE miRNA 3'UTR clone | Inquiry |
| CDCL184578 | Human HIST2H2BE ORF clone(NM_003528.2) | Inquiry |
| CDCR240784 | Mouse Gm10406 ORF Clone(NM_001164727.1) | Inquiry |
| CDCR274683 | Mouse Hist2h2be ORF Clone(NM_178214.3) | Inquiry |
| CDCS411346 | Human HIST2H2BE ORF Clone (BC069193) | Inquiry |
| CDCS411347 | Human HIST2H2BE ORF Clone (BC096121) | Inquiry |
Recent Research Progress
The H2B gene encodes the H2B protein which is a member of the histone family. Related research shows that mono-ubiquitination of H2B (ubH2B) in the histone tail (at Lys-123 in yeast or Lys-120 in humans) is a conserved modification that has been implicated in the regulation of transcription, replication, and DNA repair processes.
Histone H2B ubiquitination plays an important role in transcription regulation, and ubH2B inhibits recruitment of elongation factors. In addition, the splicing factor SART3, which has histone chaperone activity, binds to histones and enhances deubiquitination of H2B by the deubiquitinating enzyme, Usp15. It has recently been reported that ubH2B is enriched at the intron-exon boundaries in yeast, drosophila and humans, suggesting a novel link between ubH2B and co-transcriptional pre-mRNA splicing. It has been shown that H2B K34 ubiquitylation by the mammalian male-specific lethal (MSL) complex (MOF-MSL) is part of the protein networks involved in early steps of transcription elongation.
Histone H2B O-GlcNAcylation is an important posttranslational modification during gene transcription. Recent studies also suggest that histone H2B is O-GlcNAcylated at residue S112 by O-GlcNAc transferase (OGT) in vitro. H2B S112 O-GlcNAcylation fluctuates in response to extracellular glucose through the hexosamine biosynthesis pathway (HBP) and promotes H2B K120 monoubiquitination and transcriptional activation. Here some researchers found that the energy-sensing adenosine-monophosphateactivated protein kinase (AMPK) could suppress histone H2B O-GlcNAcylation.
Some researches proved that phosphorylation of histone H2B at serine 36 (H2BS36) have an effect on fat formation in early period. Some data showed that adipogenic stimuli triggered nuclear translocation of S6K1, leading to H2BS36 phosphorylation and recruitment of enhancer of zeste homolog 2 (EZH2) to histone H3, which mediated trimethylation of H3 at lysine 27 (H3K27). This blocked Wnt gene expression and induced upregulation of proliferator-activated receptor-γ (PPAR γ) and CCAAT/enhancer binding protein-α (C/EBPα), which drived adipogenesis. S6K1, a key downstream effector of the mammalian target of rapamycin (mTOR) signaling pathway, plays a critical role in a number of key catabolic responses, including protein, nucleotide, and lipid synthesis.
Figure 1. Schematic depicting of a role for S6K1 in the transcriptional regulation mediated by H2B phosphorylation and H3 trimethylation. (Sang Ah Yi, et al. 2016).
Several reports show that the Spt-Ada-Gcn5-acetyltransferase (SAGA)-mediated H2B deubiquitination controls the development of neuronal connectivity in the drosophila visual system. Loss of Ataxin-7, a SAGA subunit, reduces H2B ubiquitination and leads to neural and retinal degeneration, impaired movement, and early lethality.
Many studies have reported that reduced ubiquitination of histone H2B (H2Bub1) may create a pro-tumoral microenvironment. And reduced H2Bub1 is associated with colitis and colorectal cancer in humans. H2Bub1, primarily by the ubiquitin ligase (E3) ring finger protein 20 (RNF20), is reduced in many advanced cancers. Notably, colon and colorectal tumors in human ulcerative colitis patient showed downregulation of H2Bub1 and RNF20 in both epithelium and stroma. Tarcic et al. reports that downregulation of H2Bub1 and RNF20 promotes chronic colonic inflammation and inflammation-associated colorectal cancer in mice and humans, partly by augmenting nuclear factor kappa B (NF-kB) activity and attenuating the anti-tumoral T cell response. Downregulation of H2Bub1 and RNF20 favors recruitment of p65-containing NF-kB dimers over repressive p50 homodimers, and decreases the heterochromatin mark histone H3 lysine 9 trimethylation (H3K9me3) on a subset of NF-kB target genes to augment their transcription. What needs to be explained here is that p65 and p50 are subunit of NF-kB transcription factor.
Figure 2. Schematic depicting of downregulation of H2Bub1 and RNF20 promotes chronic colonic inflammation and inflammation-associated colorectal cancer. (Ohad Tarcic, et al. 2016).
Loss of global H2Bub1 detected by immunohistochemical staining has been reported in a number of cancers including breast, colorectal and parathyroid. In the case of parathyroid cancer, a mechanistic explanation for the loss of H2Bub1 is provided by the frequent occurrence of mutations in the tumour suppressor cell division cycle protein 73 homolog (CDC73), leading to the disruption of the RNA polymerase II-associated factor 1 (PAF1) transcriptional complex. Related research shows that basal levels of H2Bub1 were found to be unchanged when comparing normal mammary epithelium with benign breast tumour; however, in malignant and metastatic breast cancer cells, H2Bub1 levels were found to be significantly reduced.
References: